Establishing connectivity through microdissections of midbrain stimulation-related neural circuits

Georgios P Skandalakis,Clemens Neudorfer,Caitlin A Payne,Evalina Bond,Armin D Tavakkoli,Jessica Barrios-Martinez,Anne C Trutti,Christos Koutsarnakis,Volker A Coenen,Spyridon Komaitis,Constantinos G Hadjipanayis,George Stranjalis,Fang-Cheng Yeh,Layla Banihashemi,Jennifer Hong,Andres M Lozano,Michael Kogan,Andreas Horn,Linton T Evans,Aristotelis Kalyvas

DOI: https://doi.org/10.1093/brain/awae173

IF: 14.5

2024-05-31

Brain

Abstract:Comprehensive understanding of the neural circuits involving the ventral tegmental area is essential for elucidating the anatomo-functional mechanisms governing human behaviour as well as the therapeutic and adverse effects of deep brain stimulation for neuropsychiatric diseases. While the ventral tegmental area has been successfully targeted with deep brain stimulation for different neuropsychiatric diseases, the axonal connectivity of the region has not been fully understood. Here using fiber micro-dissections in human cadaveric hemispheres, population-based high-definition fiber tractography, and previously reported deep brain stimulation hotspots, we find that the ventral tegmental area participates in an intricate network involving the serotonergic pontine nuclei, basal ganglia, limbic system, basal forebrain, and prefrontal cortex, which is implicated in the treatment of obsessive-compulsive disorder, major depressive disorder, Alzheimer's disease, cluster headaches, and aggressive behaviors.

neurosciences,clinical neurology

What problem does this paper attempt to address?

This paper aims to address the comprehensive understanding of the neural circuits associated with the ventral tegmental area (VTA) in the human brain. The VTA plays a crucial role in regulating human behavior and the therapeutic effects and side effects of deep brain stimulation (DBS) for neuropsychiatric disorders such as obsessive-compulsive disorder, major depressive disorder, Alzheimer's disease, cluster headache, and aggressive behavior. Despite the use of VTA in DBS treatment for various neuropsychiatric disorders, the understanding of its axonal connectivity remains insufficient.

The researchers utilized fiber microdissection on human brain specimens, high-resolution diffusion magnetic resonance imaging (dMRI), and population-based template analysis to reveal that the VTA is involved in a complex network that includes the serotonergic raphe nuclei, basal ganglia, limbic system, basal forebrain, and prefrontal cortex. These structures are associated with the treatment of obsessive-compulsive disorder, major depressive disorder, Alzheimer's disease, cluster headache, and aggressive behavior.

The research methods included detailed anatomical dissection of human brain specimens in combination with high-definition fiber tracking techniques and the identification of DBS hotspots previously reported to determine the neural circuits involving the VTA. Furthermore, they used the Lead-DBS software to analyze reported DBS parameters to identify the DBS targets involved in the identified fiber bundles.

Through these methods, they discovered the connections between the VTA and multiple brain regions and proposed zoning of the VTA, which contributes to the selection of personalized DBS strategies to optimize therapeutic effects and minimize potential side effects. The paper also discusses how these findings provide a structural basis for DBS in the VTA region and may guide future DBS target selection and prognosis planning.